As the association of β2M overexpression was significantly higher in those patients with OCSCC and lymph node metastasis (N+) than in those without lymph node metastasis (N-), β2M may promote metastasis in OCSCC. Here, B2M is linked to metastatic malignant neoplasm in the lymph nodes.